Literature DB >> 12971756

Kinetics of metal ion exchange between citric acid and serum transferrin.

Wesley R Harris1, Zhepeng Wang, Claire Brook, Binsheng Yang, Ashraful Islam.   

Abstract

The exchange of Fe(3+), Tb(3+), In(3+), Ga(3+), and Al(3+) between the C-terminal metal-binding site of the serum iron transport protein transferrin and the low-molecular-mass serum chelating agent citrate has been studied at pH 7.4 and 25 degrees C. The removal of Ga(3+), In(3+), and Al(3+) follows simple saturation kinetics with respect to the citrate concentration. In contrast, removal of both Fe(3+) and Tb(3+) shows a combination of saturation and first-order kinetic behavior with respect to the citrate concentration. The saturation component is consistent with a mechanism for metal release in which access to the bound metal is controlled by a rate-limiting conformational change in the protein. The first-order kinetic pathway is very rapid for Tb(3+), and this is attributed to a direct attack of the citrate on the Tb(3+) ion within the closed protein conformation. It is suggested that this pathway is more readily available for Tb(3+) because of the larger coordination number for this cation and the presence of an aquated coordination site in the Tb(3+)-CO(3)-Tf ternary complex. There is relatively little variation in the k(max) values for the saturation pathway for Tb(3+), Ga(3+), Al(3+), and In(3+), but the k(max) value for Fe(3+) is significantly smaller. It is suggested that protein interactions across the interdomain cleft of transferrin largely control the release of the first group of metal ions, while the breaking of stronger metal-protein bonds slows the rate of iron release. The rates of metal binding to apotransferrin are clearly controlled in large part by the hydrolytic tendencies of the free metal ions. For the more amphoteric metal ions Al(3+) and Ga(3+), there is rapid protein binding, and the addition of citrate actually retards this reaction. In contrast, the nonamphoteric In(3+) ion binds very slowly in the absence of citrate, presumably due to the rapid formation of polymeric In-hydroxo complexes upon addition of the unchelated metal ion to the pH 7.4 protein solution. The addition of citrate to the reaction accelerates the binding of In(3+) to apoTf, presumably by forming soluble, mononuclear In-citrate complexes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12971756     DOI: 10.1021/ic034009o

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  6 in total

1.  The crystal structure of iron-free human serum transferrin provides insight into inter-lobe communication and receptor binding.

Authors:  Jeremy Wally; Peter J Halbrooks; Clemens Vonrhein; Mark A Rould; Stephen J Everse; Anne B Mason; Susan K Buchanan
Journal:  J Biol Chem       Date:  2006-06-22       Impact factor: 5.157

2.  Simultaneous Cu-, Fe-, and Zn-specific detection of metalloproteins contained in rabbit plasma by size-exclusion chromatography-inductively coupled plasma atomic emission spectroscopy.

Authors:  Shawn A Manley; Simon Byrns; Andrew W Lyon; Peter Brown; Jürgen Gailer
Journal:  J Biol Inorg Chem       Date:  2008-09-10       Impact factor: 3.358

3.  The structure and evolution of the murine inhibitor of carbonic anhydrase: a member of the transferrin superfamily.

Authors:  Brian E Eckenroth; Anne B Mason; Meghan E McDevitt; Lisa A Lambert; Stephen J Everse
Journal:  Protein Sci       Date:  2010-09       Impact factor: 6.725

4.  Site-specific rate constants for iron acquisition from transferrin by the Aspergillus fumigatus siderophores N',N'',N'''-triacetylfusarinine C and ferricrocin.

Authors:  A H T Hissen; M M Moore
Journal:  J Biol Inorg Chem       Date:  2005-03-16       Impact factor: 3.358

Review 5.  Kinetics of iron release from transferrin bound to the transferrin receptor at endosomal pH.

Authors:  Ashley N Steere; Shaina L Byrne; N Dennis Chasteen; Anne B Mason
Journal:  Biochim Biophys Acta       Date:  2011-06-15

6.  Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding.

Authors:  Huifang Peng; Hongwei Jin; Huiqin Zhuo; Heqing Huang
Journal:  Oncotarget       Date:  2017-07-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.